COCIR Concept on Medical Software

COCIRCOCIR issued an easy-to-use tool to help determine whether software is a medical device or not. Since the revision of the European Medical Device Directive, in force as of 21 March 2010, the definition for medical devices also includes software used for diagnostic and therapeutic purposes. In December 2009, the European Commission decided to develop a European guidance document to clarify which standalone software is a medical device in its own right.

However, European Member States still interpret current regulation inconsistently, which results in unfair competition and different levels of regulatory control affecting patients, users and COCIR's industry members.

The COCIR decision tree together with the explanatory text and examples may help to solve this situation. COCIR has designed this simple tool to determine whether software is to be considered as a medical device in the European regulatory framework. The COCIR decision tree has been developed based on discussions with various stakeholders. It is offered to the European Commission for inclusion in the future European guidance document on Qualification and Classification of Medical Software.

Koen Cobbaert, COCIR Medical Software Task Force Chair stated "With the COCIR decision tree, you can easily find out whether a software application is considered as a medical device and thus must be CE-marked. We are anxiously awaiting European guidance as we see different approaches among regulators."

Nicole Denjoy, COCIR Secretary General, who presented the COCIR tool to the Steering Committee of the Global Harmonisation Task Force (GHTF) in November and said "This decision tree could be a step forward to global convergence of regulation of medical software."

COCIR is freely sharing this concept and is seeking international acceptance. Comments and suggestions on the COCIR decision tree are welcome and can be sent to Olivier Deneve at This email address is being protected from spambots. You need JavaScript enabled to view it..

About COCIR
COCIR is the voice of the European Radiological, Electromedical and Healthcare IT Industry. COCIR is a non-profit trade association, founded in 1959, representing the medical technology industry in Europe. COCIR's members play a driving role in developing the future of healthcare in Europe and worldwide. COCIR moved to Brussels in January 2006, establishing a permanent office in Brussels to better represent industry in its relations with the European institutions. In February 2007, COCIR opened a China Desk in Beijing to strengthen its presence and support for its members in China.

www.cocir.org

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...